Bank of America (BAC) Stock Analysis: Falls 0.68%, Testing Support Level

As the chart shows, the price is hugging the lower Bollinger band ($48.42), while the band midpoint ($50.98) coincides with the 20-day average. The %B reading of 20% places the price in the lower fifth of the bands. Band width of 10.0% is normal, so this is a grind lower rather than a panic.

Oscillators and Momentum

The momentum indicators disagree, which is where the story gets interesting. The Stochastic oscillator reads 6.5 (%K) against 30.9 (%D), deeply oversold, meaning the close sits near the bottom of its recent high-low range. The 14-day RSI, a gauge of how strongly recent gains compare with losses, is 34.4, still neutral. Sellers are in control, but the RSI has not yet reached the sub-30 zone that typically marks exhaustion. MACD, which tracks the gap between fast and slow moving averages, is at -1.441 against a signal line of -1.626. The histogram is +0.185, a positive momentum reading, as the chart below shows. Put simply, the downward push is weakening even though the trend has not turned. That can precede a bounce, but a bounce is not a reversal, and the MACD remains below zero.

Volatility and Volume

The 14-day average true range (ATR), a measure of typical daily swing, is $1.23, or 2.5% of the price, moderate volatility. Friday's volume was 36.2 million shares, about 0.8 times the 20-day average of 44.3 million. A decline on lighter-than-normal turnover suggests sellers are not accelerating. However, on-balance volume (OBV), which adds volume on up days and subtracts it on down days, is falling, so money flow still confirms the downtrend. The code-computed technical bias is neutral: none of seven bullish signals, and two of seven bearish ones (a bounce into the 20-day average within a downtrend, and falling OBV).

Fundamental Context

According to its SEC filing (Form 10-Q, filed October 30, 2026), Bank of America reported quarterly revenue of $29.96 billion for the quarter ended September 30, up 3.2% from $29.04 billion a year earlier. Net income was $6.93 billion, compared with $8.33 billion a year earlier, with diluted earnings per share of $0.91. Revenue grew while profit fell, a mix that helps explain why the shares have struggled to hold gains.

Key Levels and Scenarios

The nearest floor is the 20-day support at $49.42, backed by the three-month low of $49.17. A close below that low would open the path toward the lower Bollinger band at $48.42 and the volatility-based level of $47.58 (price minus 1.5 times ATR). On the upside, a recovery first meets the 20-day average at $50.98 and the ATR-based level of $51.26, then resistance at $54.58.

Technical Verdict: HOLD (wait & see)

The indicators point to HOLD (wait & see), in line with the neutral bias: - Trend: price below the 20-day and 50-day averages, with the 20-day average falling, and OBV falling. - Momentum: Stochastic is oversold at 6.5 and the MACD histogram is positive, but RSI at 34.4 is not oversold, so the signals do not align. - Location: price sits on support, where the outcome hinges on whether $49.17 holds. Reference levels, drawn only from the data: - Entry range: $49.17 to $49.42 (support zone), or a close back above the 20-day average at $50.98 as confirmation - Exit target: $50.98 first, then $54.58 (20-day resistance) - Stop loss: $47.58 (price minus 1.5 times ATR) The verdict is invalidated if price closes below $49.17, which would confirm a fresh three-month low. This is technical analysis, not investment advice. In plain terms, the stock is at a make-or-break floor, and the next few sessions will show whether buyers defend it or sellers push through.

Summary Data BAC

Last price	49.42 USD
Change 1 day / 5 days / 1 month	-0.68% / -1.18% / -9.02%
Trend / MA-cross	downtrend / none
SMA20 / SMA50	50.98 / 55.24
RSI (14) / Stochastic %K	34.4 / 6.5
Bollinger %B / ATR	20% / 1.23
Support / Resistance 20 days	49.42 / 54.58
Data as of	7 November 2026 04:00 WIB

Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

Track BAC stock price daily: live levels, support/resistance and our full BAC analysis history.